Objective
Insulin-dependent diabetes mellitus (IDDM, type I diabetes) is a metabolic autoimmune disease in humans in which the ß cells of the islets of Langerhans are selectively destroyed. To date, no cure has been developed for this disease. While it has been established that the destruction of this tissue predominantly occurs due to auto-reactive recognition by CD4 T cells, the etiology of this disease as well as many of the autoantigens recognized by these T cells, are unknown.
Certain major histocompatibility com plex (MHC) class II alleles have been strongly linked with IDDM, such as DQ8 in humans and I-Ag7 in the non-obese diabetic (NOD) mouse, a spontaneous model for type I diabetes. In order to find a cure for IDDM, the target antigens that drive auto-reactive T cell recognition need to be identified and new immunotherapies need to be developed. Therefore, the main objectives of this project are the identification of one of these auto-antigens as well as the development of a novel DNA vaccine. To reach the first objective, several new in silico and in vitro approaches will be used for the identification of antigen candidates, that could possibly be recognized by a well characterized diabetogenic T cell clone called BDC2.5. Recombinant antigens will be generated in order to screen for the activation of BDC2.5.
We will finally evaluate the natural T and B cell response against this autoantigen in vivo in the NOD mouse in order to assess the value of protein homologues for the development of new diagnostics for disease prediction in humans. The second objective will be the generation of a novel DNA vaccine coding for soluble I-Ag7/peptide dimers. We will use the BDC2.5 system as a model to explore its efficacy in the NOD mouse. I-Ag7/peptide tetramers will allow us to evaluate the specific T cell response quantitatively as well as qualitatively. These experiments will facilitate the design of equivalent vaccines for the prevention of IDDM in human patients.
Fields of science (EuroSciVoc)
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.
- natural sciences biological sciences genetics DNA
- medical and health sciences clinical medicine endocrinology diabetes
- medical and health sciences basic medicine immunology autoimmune diseases
- medical and health sciences basic medicine pharmacology and pharmacy pharmaceutical drugs vaccines
- medical and health sciences basic medicine immunology immunotherapy
You need to log in or register to use this function
Keywords
Project’s keywords as indicated by the project coordinator. Not to be confused with the EuroSciVoc taxonomy (Fields of science)
Project’s keywords as indicated by the project coordinator. Not to be confused with the EuroSciVoc taxonomy (Fields of science)
Programme(s)
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
Topic(s)
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Call for proposal
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
FP6-2002-MOBILITY-12
See other projects for this call
Funding Scheme
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
IRG - Marie Curie actions-International re-integration grants
Coordinator
BARCELONA
Spain
The total costs incurred by this organisation to participate in the project, including direct and indirect costs. This amount is a subset of the overall project budget.